Yuli Cai

5.7k total citations · 1 hit paper
41 papers, 3.7k citations indexed

About

Yuli Cai is a scholar working on Epidemiology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yuli Cai has authored 41 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hematology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yuli Cai's work include Liver Disease Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yuli Cai is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yuli Cai collaborates with scholars based in China, United States and Australia. Yuli Cai's co-authors include Fan Yang, Shaobo Shi, Congxin Huang, Mu Qin, Bo Shen, He Huang, Xu Liu, Tao Liu, Bo Yang and Wei Gong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Yuli Cai

38 papers receiving 3.6k citations

Hit Papers

Association of Cardiac Injury With Mortality in Hospitali... 2020 2026 2022 2024 2020 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuli Cai China 12 2.6k 1.6k 946 691 366 41 3.7k
Xiaoyan Wu China 12 2.3k 0.9× 1.4k 0.9× 776 0.8× 618 0.9× 449 1.2× 31 3.3k
Mu Qin China 4 2.6k 1.0× 1.6k 1.0× 906 1.0× 673 1.0× 258 0.7× 5 3.3k
Yongzhen Fan China 8 2.3k 0.9× 1.4k 0.9× 768 0.8× 603 0.9× 222 0.6× 9 3.0k
Ying‐Ying Zheng China 22 1.5k 0.6× 870 0.5× 942 1.0× 510 0.7× 409 1.1× 113 3.6k
Nardo J. M. van der Meer Netherlands 19 3.6k 1.4× 2.0k 1.3× 465 0.5× 1.3k 1.9× 540 1.5× 72 5.8k
Marianna Adamo Italy 26 1.2k 0.5× 750 0.5× 2.1k 2.2× 281 0.4× 549 1.5× 147 3.6k
Ritesh Gupta India 21 1.1k 0.4× 444 0.3× 498 0.5× 558 0.8× 414 1.1× 51 2.7k
Dario Cani Italy 10 1.0k 0.4× 638 0.4× 773 0.8× 206 0.3× 117 0.3× 17 1.8k

Countries citing papers authored by Yuli Cai

Since Specialization
Citations

This map shows the geographic impact of Yuli Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Cai more than expected).

Fields of papers citing papers by Yuli Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuli Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Cai. The network helps show where Yuli Cai may publish in the future.

Co-authorship network of co-authors of Yuli Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuli Cai. A scholar is included among the top collaborators of Yuli Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuli Cai. Yuli Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Riken, Jie Quan, Zhaojun Chen, et al.. (2025). Association between NoSAS score and cardiovascular disease in patients with obstructive sleep apnea. Frontiers in Cardiovascular Medicine. 12. 1572055–1572055.
2.
Li, Qingwen, Xuan Niu, Yuli Cai, Lili Li, & Zhongyuan Xia. (2025). Exposure to submicroplastics promotes the progression of nonalcoholic fatty liver disease in ApoE-deficient mice. Toxicology. 515. 154137–154137. 4 indexed citations
3.
Su, Ke, et al.. (2024). Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline. European Journal of Pharmacology. 983. 176905–176905. 3 indexed citations
4.
Li, Junfeng, Yan Huang, Xinyu Yang, et al.. (2024). Tyrosine-phosphorylated DNER sensitizes insulin signaling in hepatic gluconeogenesis by inducing proteasomal degradation of TRB3. Molecular Metabolism. 83. 101927–101927. 3 indexed citations
5.
Chen, Ying, et al.. (2024). Identification of Mitophagy-Associated Genes for the Prediction of Metabolic Dysfunction-Associated Steatohepatitis Based on Interpretable Machine Learning Models. Journal of Inflammation Research. Volume 17. 2711–2730. 3 indexed citations
6.
He, Zhiwei, et al.. (2023). Adipokines in atherosclerosis: unraveling complex roles. Frontiers in Cardiovascular Medicine. 10. 1235953–1235953. 21 indexed citations
7.
Chang, Lixian, Jingliao Zhang, Binghang Liu, et al.. (2023). An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia. SHILAP Revista de lepidopterología. 5(3). 180–186.
8.
Chen, Xiaolin, et al.. (2023). Dapagliflozin Ameliorates Ovulation Disorders via Attenuating Activated Microglia-Mediated Hypothalamic Inflammation in HFD-Fed Mice. Neuroendocrinology. 114(4). 331–347. 7 indexed citations
9.
Chen, Xiaolin, Zhuoni Xiao, Yuli Cai, Lili Huang, & Chen Chen. (2022). Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic–pituitary–ovarian axis. Trends in Endocrinology and Metabolism. 33(3). 206–217. 55 indexed citations
10.
Su, Yanlin, Wenzhao Wang, Fei Liu, et al.. (2022). Blosozumab in the treatment of postmenopausal women with osteoporosis: a systematic review and meta-analysis. Annals of Palliative Medicine. 11(10). 3203–3212. 8 indexed citations
11.
Chang, Lixian, Li Zhang, Yang Wan, et al.. (2022). Phenotypic and genotypic correlation evaluation of 148 pediatric patients with Fanconi anemia in a Chinese rare disease cohort. Clinica Chimica Acta. 539. 41–49. 2 indexed citations
12.
Cao, Dedong, Yuli Cai, Qian Li, et al.. (2021). Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China. International Journal of Infectious Diseases. 105. 113–119. 7 indexed citations
13.
Liu, Fang, Lixian Chang, Lipeng Liu, et al.. (2021). Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia. BMC Pediatrics. 21(1). 102–102. 10 indexed citations
14.
Cai, Yuli, Chao Liu, Ye Guo, et al.. (2021). Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China. International Journal of Hematology. 113(3). 413–421. 7 indexed citations
15.
Chang, Lixian, Meihui Yi, Yuli Cai, et al.. (2020). Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine. Annals of Hematology. 100(1). 53–61. 6 indexed citations
16.
Cai, Yuli, Shaobo Shi, Fan Yang, et al.. (2020). Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history. Diabetes Research and Clinical Practice. 169. 108437–108437. 35 indexed citations
17.
Cai, Yuli, Tianshu Zeng, Zhongyuan Wen, & Lulu Chen. (2017). Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis. Diabetes Therapy. 9(1). 177–191. 11 indexed citations
18.
Guo, Ting, Shih-Lung Woo, Xin Guo, et al.. (2016). Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity. Scientific Reports. 6(1). 22612–22612. 92 indexed citations
20.
Cai, Yuli, et al.. (2012). Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression. Molecular Biology Reports. 39(12). 10705–10711. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026